Baring India Private Equity Fund III has sold a 7.36% stake in India-based active pharmaceutical ingredients manufacturer Shilpa Medicare for INR3.06b (approximately USD41.8m) through an open market transaction. Baring PE India retains a 1.36% stake in the company. Read more… Read More
Vickers Venture Partners, ZTC Private Markets, and Singapura Finance led a USD21m investment in Singapore-based fintech MatchMove, with participation from NTT Investment Partners, Iconic World, and V V Pentafond. Read more… Read More
Openspace Ventures led a USD3m Series A for Thailand-based agtech Freshket, with participation from ECG-Research, Innospace, Tanihub co-founders Pamitra Wineka and Ivan Sustiawan. Existing investors Denis Asia Pacific and Thai family office Seedersclub also participated. Read more… Read More
A group of shareholders including CVC Capital Partners will exit their stakes in Indonesia-based personal care products manufacturer Softex Indonesia via a USD1.2b sale to Kimberly-Clark Corp. CVC Capital Partners originally invested in the company in 2015 through CVC Capital Partners Asia Pacific IV. Read more… Read More
PAG has reached a USD1.5b final close for its Asian Loan Fund IV, a pan-Asia private debt vehicle. Read more… Read More
Existing investors KKR, through its KKR Asian Fund III, and TPG have invested an additional USD220m in Singapore-based proptech PropertyGuru. Read more… Read More
India-focused VC 3one4 Capital has reached a USD40m first close for its third VC fund. The vehicle, which targets USD100m, aims to invest in early-stage startups across sectors such as SaaS and enterprise automation, direct-to-consumer, media and content, fintech, and deep technology in India. Read more… Read More
LeapFrog Investments, SBI Investment, Xiaomi, Alpha JWC Ventures, and Intudo Ventures have invested a USD54m Series B for Indonesia-based Insurtech PasarPolis. Existing Series A investors also participated in the round. Read more… Read More
Tigermed and Yingke PE led a USD100m Series C for Adlai Nortye, a China-based clinical-stage biopharmaceutical company focused on developing immuno-oncology medicines, with participation from ATCG Holdings, ICBC Asset Management, and two funds affiliated with Yingke PE. Read more… Read More
SoftBank, through its Vision Fund II, led a USD100m Series C for Biofourmis, a US-based AI and digital therapeutics startup originally founded in Singapore, with participation from returning investors Openspace Ventures, MassMutual Ventures, Sequoia Capital, and EDBI. Read more… Read More
(default archive template)